4//SEC Filing
Cadavid Diego 4
Accession 0000899243-20-016382
CIK 0001680581other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:10 PM ET
Size
8.7 KB
Accession
0000899243-20-016382
Insider Transaction Report
Form 4
Cadavid Diego
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2020-06-10$4.83/sh+401$1,937→ 67,186 total - Sale
Common Stock
2020-06-10$22.00/sh−401$8,822→ 66,785 total - Exercise/Conversion
Stock Option (right to buy)
2020-06-10−401→ 13,736 totalExercise: $4.83Exp: 2028-07-10→ Common Stock (401 underlying)
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2019.
- [F2]The shares underlying the option are scheduled to vest in equal quarterly installments from July 16, 2018 through July 15, 2022.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001778713
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 5:10 PM ET
- Size
- 8.7 KB